Company Financials

Pharma Mar, SA Financials

Euro

business Pharma Mar, SA Company Profile

Main Stock Listing

BME: PHM

Market Capitalization €1.31 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 38.41
Forward PE 23.41
Price to Sales TTM €7.18
Price to Book MRQ €6.61
Enterprise to Revenue 6.75
Enterprise to EBITDA 44.87

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 18.97%
Operating Margin -11.10%
Return on Assets TTM 4.07%
Return on Equity TTM 17.91%

Income Statement

Revenue TTM €179,276,000
Revenue per Share TTM €10.28
Quarterly Revenue Growth -21.90%
Gross Profit TTM €169,476,992
EBITDA €21,046,000
Net Income to Common TTM €34,005,000
Diluted EPS TTM €1.95
Quarterly Earnings Growth YoY 31.54%

Balance Sheet

Total Cash MRQ €146,668,000
Total Cash per Share MRQ €8.41
Total Debt MRQ
Total Debt to Equity MRQ 25.48
Current Ratio MRQ 2.73
Book Value per Share MRQ €11.33

Cash Flow

Operating Cash Flow TTM €21,239,000
Levered Free Cash Flow TTM €9,805,500

PHM Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 17,432,228
Float Shares 13,463,781
Avg 10 Volume 32,048
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 18.90%
% Held by Institutions 8.02%

Stock Price Summary

Beta 0.25
Fifty Two Week Low €65.00
Fifty Two Week High €105.80
Fifty Two Week Change -1.05%
Day 50 MA €74.91
Day 200 MA €80.42

Dividends and Splits

Forward Annual Dividend Rate €3.20
Forward Annual Dividend Yield 4.19%
Trailing Annual Dividend Rate €0.80
Trailing Annual Dividend Yield 1.05%
Payout Ratio 40.95%
Dividend Date
Ex Dividend Date 2025-06-25
Last Split Factor
Last Split Date 2020-07-22